The updated and most recent evidence of the occurrence and co-occurrence of mycotoxins.
CMS Blinks in ‘Flap’ Flap; Biomarker Testing; ‘What If’ Moment in Cancer Screening
Facing backlash from doctors, patients, and advocacy groups, the Centers for Medicare & Medicaid Services (CMS) has backed down from a proposal that would have